University of Texas/MD Anderson Cancer Center Dept. of MD Anderson (13) — Houston, Texas

University of Texas/MD Anderson Cancer Center Dept. of MD Anderson (13) is a clinical research site located in Houston, Texas, United States 77030-4009.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Texas/MD Anderson Cancer Center Dept. of MD Anderson (13) has participated in 1 clinical trials.

Therapeutic areas: Gastrointestinal Stromal Tumor (GIST).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas/MD Anderson Cancer Center Dept. of MD Anderson (13)?

University of Texas/MD Anderson Cancer Center Dept. of MD Anderson (13) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas/MD Anderson Cancer Center Dept. of MD Anderson (13) conducted?

University of Texas/MD Anderson Cancer Center Dept. of MD Anderson (13) has 1 clinical trials on record. Their work covers Gastrointestinal Stromal Tumor (GIST).

Is University of Texas/MD Anderson Cancer Center Dept. of MD Anderson (13) accredited by Crixeo Health?

University of Texas/MD Anderson Cancer Center Dept. of MD Anderson (13) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas/MD Anderson Cancer Center Dept. of MD Anderson (13)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.